GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Anhui Wanbang Pharmaceutical Technology Co Ltd (SZSE:301520) » Definitions » 12-1 Month Momentum %

Anhui Wanbang Pharmaceutical Technology Co (SZSE:301520) 12-1 Month Momentum % : N/A% (As of May. 12, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Anhui Wanbang Pharmaceutical Technology Co 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-05-12), Anhui Wanbang Pharmaceutical Technology Co's 12-1 Month Momentum % is N/A%.

The industry rank for Anhui Wanbang Pharmaceutical Technology Co's 12-1 Month Momentum % or its related term are showing as below:

SZSE:301520's 12-1 Month Momentum % is not ranked *
in the Drug Manufacturers industry.
Industry Median: -6.39
* Ranked among companies with meaningful 12-1 Month Momentum % only.

Competitive Comparison of Anhui Wanbang Pharmaceutical Technology Co's 12-1 Month Momentum %

For the Drug Manufacturers - Specialty & Generic subindustry, Anhui Wanbang Pharmaceutical Technology Co's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Anhui Wanbang Pharmaceutical Technology Co's 12-1 Month Momentum % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Anhui Wanbang Pharmaceutical Technology Co's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Anhui Wanbang Pharmaceutical Technology Co's 12-1 Month Momentum % falls into.



Anhui Wanbang Pharmaceutical Technology Co  (SZSE:301520) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Anhui Wanbang Pharmaceutical Technology Co  (SZSE:301520) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Anhui Wanbang Pharmaceutical Technology Co 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Anhui Wanbang Pharmaceutical Technology Co's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Anhui Wanbang Pharmaceutical Technology Co (SZSE:301520) Business Description

Traded in Other Exchanges
N/A
Address
southwest corner of the intersection of Mingzhu Avenue and Huolongdi Road, Building 1, Anhui Wanbang Pharmaceutical, High-tech Zone, Anhui, Hefei, CHN, 230000
Anhui Wanbang Pharmaceutical Technology Co Ltd is a one-stop CRO service platform that engages in the entire process from pharmaceutical development to clinical research of innovative drugs, improved new drugs and generic drugs. It aims to provide drug research and development and clinical trials for drug launch, including pharmaceutical research, clinical services, biological sample analysis and testing, SMO services and data statistics and analysis.

Anhui Wanbang Pharmaceutical Technology Co (SZSE:301520) Headlines

No Headlines